Cargando…

Budget impact from the incorporation of positron emission tomography – computed tomography for staging lung cancers

OBJECTIVE: To estimate the budget impact from the incorporation of positron emission tomography (PET) in mediastinal and distant staging of non-small cell lung cancer. METHODS: The estimates were calculated by the epidemiological method for years 2014 to 2018. Nation-wide data were used about the in...

Descripción completa

Detalles Bibliográficos
Autores principales: Biz, Aline Navega, Caetano, Rosângela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculdade de Saúde Pública da Universidade de São Paulo 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544594/
https://www.ncbi.nlm.nih.gov/pubmed/26274871
http://dx.doi.org/10.1590/S0034-8910.2015049005447
_version_ 1782386692978638848
author Biz, Aline Navega
Caetano, Rosângela
author_facet Biz, Aline Navega
Caetano, Rosângela
author_sort Biz, Aline Navega
collection PubMed
description OBJECTIVE: To estimate the budget impact from the incorporation of positron emission tomography (PET) in mediastinal and distant staging of non-small cell lung cancer. METHODS: The estimates were calculated by the epidemiological method for years 2014 to 2018. Nation-wide data were used about the incidence; data on distribution of the disease´s prevalence and on the technologies’ accuracy were from the literature; data regarding involved costs were taken from a micro-costing study and from Brazilian Unified Health System (SUS) database. Two strategies for using PET were analyzed: the offer to all newly-diagnosed patients, and the restricted offer to the ones who had negative results in previous computed tomography (CT) exams. Univariate and extreme scenarios sensitivity analyses were conducted to evaluate the influence from sources of uncertainties in the parameters used. RESULTS: The incorporation of PET-CT in SUS would imply the need for additional resources of 158.1 BRL (98.2 USD) million for the restricted offer and 202.7 BRL (125.9 USD) million for the inclusive offer in five years, with a difference of 44.6 BRL (27.7 USD) million between the two offer strategies within that period. In absolute terms, the total budget impact from its incorporation in SUS, in five years, would be 555 BRL (345 USD) and 600 BRL (372.8 USD) million, respectively. The costs from the PET-CT procedure were the most influential parameter in the results. In the most optimistic scenario, the additional budget impact would be reduced to 86.9 BRL (54 USD) and 103.8 BRL (64.5 USD) million, considering PET-CT for negative CT and PET-CT for all, respectively. CONCLUSIONS: The incorporation of PET in the clinical staging of non-small cell lung cancer seems to be financially feasible considering the high budget of the Brazilian Ministry of Health. The potential reduction in the number of unnecessary surgeries may cause the available resources to be more efficiently allocated.
format Online
Article
Text
id pubmed-4544594
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Faculdade de Saúde Pública da Universidade de São Paulo
record_format MEDLINE/PubMed
spelling pubmed-45445942015-08-31 Budget impact from the incorporation of positron emission tomography – computed tomography for staging lung cancers Biz, Aline Navega Caetano, Rosângela Rev Saude Publica Original Articles OBJECTIVE: To estimate the budget impact from the incorporation of positron emission tomography (PET) in mediastinal and distant staging of non-small cell lung cancer. METHODS: The estimates were calculated by the epidemiological method for years 2014 to 2018. Nation-wide data were used about the incidence; data on distribution of the disease´s prevalence and on the technologies’ accuracy were from the literature; data regarding involved costs were taken from a micro-costing study and from Brazilian Unified Health System (SUS) database. Two strategies for using PET were analyzed: the offer to all newly-diagnosed patients, and the restricted offer to the ones who had negative results in previous computed tomography (CT) exams. Univariate and extreme scenarios sensitivity analyses were conducted to evaluate the influence from sources of uncertainties in the parameters used. RESULTS: The incorporation of PET-CT in SUS would imply the need for additional resources of 158.1 BRL (98.2 USD) million for the restricted offer and 202.7 BRL (125.9 USD) million for the inclusive offer in five years, with a difference of 44.6 BRL (27.7 USD) million between the two offer strategies within that period. In absolute terms, the total budget impact from its incorporation in SUS, in five years, would be 555 BRL (345 USD) and 600 BRL (372.8 USD) million, respectively. The costs from the PET-CT procedure were the most influential parameter in the results. In the most optimistic scenario, the additional budget impact would be reduced to 86.9 BRL (54 USD) and 103.8 BRL (64.5 USD) million, considering PET-CT for negative CT and PET-CT for all, respectively. CONCLUSIONS: The incorporation of PET in the clinical staging of non-small cell lung cancer seems to be financially feasible considering the high budget of the Brazilian Ministry of Health. The potential reduction in the number of unnecessary surgeries may cause the available resources to be more efficiently allocated. Faculdade de Saúde Pública da Universidade de São Paulo 2015-09-10 /pmc/articles/PMC4544594/ /pubmed/26274871 http://dx.doi.org/10.1590/S0034-8910.2015049005447 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Biz, Aline Navega
Caetano, Rosângela
Budget impact from the incorporation of positron emission tomography – computed tomography for staging lung cancers
title Budget impact from the incorporation of positron emission tomography – computed tomography for staging lung cancers
title_full Budget impact from the incorporation of positron emission tomography – computed tomography for staging lung cancers
title_fullStr Budget impact from the incorporation of positron emission tomography – computed tomography for staging lung cancers
title_full_unstemmed Budget impact from the incorporation of positron emission tomography – computed tomography for staging lung cancers
title_short Budget impact from the incorporation of positron emission tomography – computed tomography for staging lung cancers
title_sort budget impact from the incorporation of positron emission tomography – computed tomography for staging lung cancers
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544594/
https://www.ncbi.nlm.nih.gov/pubmed/26274871
http://dx.doi.org/10.1590/S0034-8910.2015049005447
work_keys_str_mv AT bizalinenavega budgetimpactfromtheincorporationofpositronemissiontomographycomputedtomographyforstaginglungcancers
AT caetanorosangela budgetimpactfromtheincorporationofpositronemissiontomographycomputedtomographyforstaginglungcancers